Filed: 8/14/2026ACC: 0001420506-26-001809
📋 What this filing means
CALIGAN PARTNERS LP filed this quarterly 13F‑HR report disclosing 26 equity positions with a total reported market value of $2.13B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
26
Positions
$2.13B
Total AUM (reported)
70.45M
Total Shares
Allocation by class
COM$982.39M46.2%
COM NEW$789.34M37.1%
SPONSORED ADS$207.61M9.8%
ADS$74.71M3.5%
COM SHS$52.33M2.5%
COM SER A$19.32M0.9%
Portfolio Concentration
Top 3$1.27B59.7%
4–10$499.18M23.5%
11–25$355.73M16.7%
Rest$1.31M0.1%
Top 3 weight
59.7%
Top 10 weight
83.2%
Voting Authority Distribution
Total shares with voting rights: 70.45M
Sole
Full voting authority
70.45M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole26
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings26
Rows:
LIQUIDIA CORPORATION
SOLEShares8.12M
TypeSH
Market value$647.32M
30.45%
Sole
8.12M
Shared
0.00
None
0.00
REVOLUTION MEDICINES INC
SOLEShares2.21M
TypeSH
Market value$414.56M
19.50%
Sole
2.21M
Shared
0.00
None
0.00
ABIVAX SA
SOLEShares1.56M
TypeSH
Market value$207.61M
9.77%
Sole
1.56M
Shared
0.00
None
0.00
VAXCYTE INC
SOLEShares2.19M
TypeSH
Market value$127.23M
5.99%
Sole
2.19M
Shared
0.00
None
0.00
EXELIXIS INC
SOLEShares1.55M
TypeSH
Market value$84.51M
3.98%
Sole
1.55M
Shared
0.00
None
0.00
TANGO THERAPEUTICS INC
SOLEShares2.50M
TypeSH
Market value$78.15M
3.68%
Sole
2.50M
Shared
0.00
None
0.00
AVALO THERAPEUTICS INC
SOLEShares3.16M
TypeSH
Market value$58.47M
2.75%
Sole
3.16M
Shared
0.00
None
0.00
XENON PHARMACEUTICALS INC
SOLEShares889.94K
TypeSH
Market value$53.72M
2.53%
Sole
889.94K
Shared
0.00
None
0.00
ADMA BIOLOGICS INC
SOLEShares6.03M
TypeSH
Market value$50.43M
2.37%
Sole
6.03M
Shared
0.00
None
0.00
LB PHARMACEUTICALS INC
SOLEShares1.44M
TypeSH
Market value$46.67M
2.20%
Sole
1.44M
Shared
0.00
None
0.00
IMMUNOCORE HLDGS PLC
SOLEShares1.38M
TypeSH
Market value$43.86M
2.06%
Sole
1.38M
Shared
0.00
None
0.00
VIRIDIAN THERAPEUTICS INC
SOLEShares2.19M
TypeSH
Market value$40.30M
1.90%
Sole
2.19M
Shared
0.00
None
0.00
VOR BIOPHARMA INC
SOLEShares1.93M
TypeSH
Market value$35.44M
1.67%
Sole
1.93M
Shared
0.00
None
0.00
SAB BIOTHERAPEUTICS INC
SOLEShares7.97M
TypeSH
Market value$31.07M
1.46%
Sole
7.97M
Shared
0.00
None
0.00
INVENTIVA SA
SOLEShares8.16M
TypeSH
Market value$30.86M
1.45%
Sole
8.16M
Shared
0.00
None
0.00
AURA BIOSCIENCES INC
SOLEShares4.30M
TypeSH
Market value$30.52M
1.44%
Sole
4.30M
Shared
0.00
None
0.00
TYRA BIOSCIENCES INC
SOLEShares806.99K
TypeSH
Market value$25.78M
1.21%
Sole
806.99K
Shared
0.00
None
0.00
OPUS GENETICS INC
SOLEShares6.08M
TypeSH
Market value$24.98M
1.17%
Sole
6.08M
Shared
0.00
None
0.00
ANIKA THERAPEUTICS INC
SOLEShares1.44M
TypeSH
Market value$21.00M
0.99%
Sole
1.44M
Shared
0.00
None
0.00
SAGIMET BIOSCIENCES INC
SOLEShares2.50M
TypeSH
Market value$19.32M
0.91%
Sole
2.50M
Shared
0.00
None
0.00
ARTIVA BIOTHERAPEUTICS INC
SOLEShares1.74M
TypeSH
Market value$16.84M
0.79%
Sole
1.74M
Shared
0.00
None
0.00
FAETH THERAPEUTICS INC
SOLEShares629.47K
TypeSH
Market value$15.74M
0.74%
Sole
629.47K
Shared
0.00
None
0.00
MBX BIOSCIENCES INC
SOLEShares200K
TypeSH
Market value$11.04M
0.52%
Sole
200K
Shared
0.00
None
0.00
VERRICA PHARMACEUTICALS INC
SOLEShares923.91K
TypeSH
Market value$5.65M
0.27%
Sole
923.91K
Shared
0.00
None
0.00
AGIOS PHARMACEUTICALS INC
SOLEShares90K
TypeSH
Market value$3.34M
0.16%
Sole
90K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
LIQUIDIA CORPORATIONSOLE | COM NEW | 8.12M | SH | $647.32M 30.45% | 8.12M | 0.00 | 0.00 |
REVOLUTION MEDICINES INCSOLE | COM | 2.21M | SH | $414.56M 19.50% | 2.21M | 0.00 | 0.00 |
ABIVAX SASOLE | SPONSORED ADS | 1.56M | SH | $207.61M 9.77% | 1.56M | 0.00 | 0.00 |
VAXCYTE INCSOLE | COM | 2.19M | SH | $127.23M 5.99% | 2.19M | 0.00 | 0.00 |
EXELIXIS INCSOLE | COM | 1.55M | SH | $84.51M 3.98% | 1.55M | 0.00 | 0.00 |
TANGO THERAPEUTICS INCSOLE | COM | 2.50M | SH | $78.15M 3.68% | 2.50M | 0.00 | 0.00 |
AVALO THERAPEUTICS INCSOLE | COM NEW | 3.16M | SH | $58.47M 2.75% | 3.16M | 0.00 | 0.00 |
XENON PHARMACEUTICALS INCSOLE | COM | 889.94K | SH | $53.72M 2.53% | 889.94K | 0.00 | 0.00 |
ADMA BIOLOGICS INCSOLE | COM | 6.03M | SH | $50.43M 2.37% | 6.03M | 0.00 | 0.00 |
LB PHARMACEUTICALS INCSOLE | COM SHS | 1.44M | SH | $46.67M 2.20% | 1.44M | 0.00 | 0.00 |
IMMUNOCORE HLDGS PLCSOLE | ADS | 1.38M | SH | $43.86M 2.06% | 1.38M | 0.00 | 0.00 |
VIRIDIAN THERAPEUTICS INCSOLE | COM | 2.19M | SH | $40.30M 1.90% | 2.19M | 0.00 | 0.00 |
VOR BIOPHARMA INCSOLE | COM NEW | 1.93M | SH | $35.44M 1.67% | 1.93M | 0.00 | 0.00 |
SAB BIOTHERAPEUTICS INCSOLE | COM NEW | 7.97M | SH | $31.07M 1.46% | 7.97M | 0.00 | 0.00 |
INVENTIVA SASOLE | ADS | 8.16M | SH | $30.86M 1.45% | 8.16M | 0.00 | 0.00 |
AURA BIOSCIENCES INCSOLE | COM | 4.30M | SH | $30.52M 1.44% | 4.30M | 0.00 | 0.00 |
TYRA BIOSCIENCES INCSOLE | COM | 806.99K | SH | $25.78M 1.21% | 806.99K | 0.00 | 0.00 |
OPUS GENETICS INCSOLE | COM | 6.08M | SH | $24.98M 1.17% | 6.08M | 0.00 | 0.00 |
ANIKA THERAPEUTICS INCSOLE | COM | 1.44M | SH | $21.00M 0.99% | 1.44M | 0.00 | 0.00 |
SAGIMET BIOSCIENCES INCSOLE | COM SER A | 2.50M | SH | $19.32M 0.91% | 2.50M | 0.00 | 0.00 |
ARTIVA BIOTHERAPEUTICS INCSOLE | COM | 1.74M | SH | $16.84M 0.79% | 1.74M | 0.00 | 0.00 |
FAETH THERAPEUTICS INCSOLE | COM NEW | 629.47K | SH | $15.74M 0.74% | 629.47K | 0.00 | 0.00 |
MBX BIOSCIENCES INCSOLE | COM | 200K | SH | $11.04M 0.52% | 200K | 0.00 | 0.00 |
VERRICA PHARMACEUTICALS INCSOLE | COM SHS | 923.91K | SH | $5.65M 0.27% | 923.91K | 0.00 | 0.00 |
AGIOS PHARMACEUTICALS INCSOLE | COM | 90K | SH | $3.34M 0.16% | 90K | 0.00 | 0.00 |
Page 1 of 2